|
Harrow Health, Inc.
Ticker Symbol: HROW CUSIP: 415858109 Previous CUSIP: 45323A201 Exchange: NCM
Company's Online Profile
BUSINESS: Harrow Health, Inc. owns a portfolio of healthcare businesses, including the nation’s leading ophthalmology pharmaceutical compounding business, ImprimisRx. The company holds large equity positions in Eton Pharmaceuticals, Surface Pharmaceuticals, Melt Pharmaceuticals, Mayfield Pharmaceuticals and Radley Pharmaceuticals, companies founded as subsidiaries of Harrow Health. The Company also owns royalty rights in certain 505(b)(2) drug candidates being developed by Eton, Surface, Melt, Mayfield and Radley.
|
Find All Related Securities for HROW
Previous Ticker Symbol: IMMY Changed: 1/02/2019
Previous Name: Imprimis Pharmaceuticals, Inc. Changed: 1/02/2019
Small Cap Stock -
Market Value $ Million
Click for current HROW price quote from the NASDAQ
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 102 Woodmont Blvd., Suite 610, Nashville, TN 37205 |
| Main Phone Number |
615-733-4730 |
| Fax Number |
Not Available |
| Investor Relations
Jamie Webb
|
615-733-4737
|
| CEO - Mark L. Baum |
CFO - Andrew R. Boll |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
